Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:413-422
Published online before print July 17, 2008, doi: 10.1161/CIRCRESAHA.107.168336
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/4/413    most recent
CIRCRESAHA.107.168336v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raake, P. W.
Right arrow Articles by Koch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raake, P. W.
Right arrow Articles by Koch, W. J.
Related Collections
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Chronic ischemic heart disease
(Circulation Research. 2008;103:413.)
© 2008 American Heart Association, Inc.


Integrative Physiology

G Protein–Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure

Philip W. Raake*, Leif E. Vinge*, Erhe Gao, Matthieu Boucher, Giuseppe Rengo, Xiongwen Chen, Brent R. DeGeorge, Jr, Scot Matkovich, Steven R. Houser, Patrick Most, Andrea D. Eckhart, Gerald W. Dorn, II, Walter J. Koch

From the George Zallie and Family Laboratory for Cardiovascular Gene Therapy (P.W.R., L.E.V., E.G., M.B., G.R., B.R.D., P.M., A.D.E., W.J.K.) and Eugene Feiner Laboratory for Vascular Biology and Thrombosis (A.D.E.), Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pa; Cardiovascular Research Center (X.C., S.R.H.), Department of Physiology, Temple University, Philadelphia, Pa; and Center for Pharmacogenomics (S.M., G.W.D.), Washington University, St Louis, Mo.

Correspondence to Philip W. Raake, MD, Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, 1025 Walnut St, Philadelphia, PA 19107. E-mail Philip.Raake{at}jefferson.edu

Myocardial G protein–coupled receptor kinase (GRK)2 is a critical regulator of cardiac β-adrenergic receptor (βAR) signaling and cardiac function. Its upregulation in heart failure may further depress cardiac function and contribute to mortality in this syndrome. Preventing GRK2 translocation to activated βAR with a GRK2-derived peptide that binds Gβ{gamma} (βARKct) has benefited some models of heart failure, but the precise mechanism is uncertain, because GRK2 is still present and βARKct has other potential effects. We generated mice in which cardiac myocyte GRK2 expression was normal during embryonic development but was ablated after birth ({alpha}MHC-CrexGRK2 fl/fl) or only after administration of tamoxifen ({alpha}MHC-MerCreMerxGRK2 fl/fl) and examined the consequences of GRK2 ablation before and after surgical coronary artery ligation on cardiac adaptation after myocardial infarction. Absence of GRK2 before coronary artery ligation prevented maladaptive postinfarction remodeling and preserved βAR responsiveness. Strikingly, GRK2 ablation initiated 10 days after infarction increased survival, enhanced cardiac contractile performance, and halted ventricular remodeling. These results demonstrate a specific causal role for GRK2 in postinfarction cardiac remodeling and heart failure and support therapeutic approaches of targeting GRK2 or restoring βAR signaling by other means to improve outcomes in heart failure.


Key Words: heart failure • myocardial infarction • conditional gene targeting • GRK2




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ito, H. Akazawa, M. Tamagawa, K. Furukawa, W. Ogawa, N. Yasuda, Y. Kudo, C.-h. Liao, R. Yamamoto, T. Sato, et al.
PDK1 coordinates survival pathways and {beta}-adrenergic response in the heart
PNAS, May 26, 2009; 106(21): 8689 - 8694.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Rengo, A. Lymperopoulos, C. Zincarelli, M. Donniacuo, S. Soltys, J. E. Rabinowitz, and W. J. Koch
Myocardial Adeno-Associated Virus Serotype 6-{beta}ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure
Circulation, January 6, 2009; 119(1): 89 - 98.
[Abstract] [Full Text] [PDF]